Dr Patricia Ares-Romero and Dr Martin Rosenzweig discuss treatment strategies for TRD, including alternative therapies and explain current barriers within the healthcare system that inhibit access.

The loss of touch with reality signaled that she didn’t just have major depression but that she had major depression with ... action to get her treated with electroconvulsive therapy (ECT), the most ...

Bright light therapy was associated with a significantly higher remission rate in patients with nonseasonal depressive ...

Prescription digital therapeutics for mental health have the potential to increase patient access to care, but major barriers ...

A recent study published in Translational Psychiatry found that ketamine, a medication typically used as an anesthetic, may ...

Scientists are learning more about how psychedelic mushrooms may alter the brain, potentially leading to long-lasting ...

Bright light therapy – commonly used to treat Seasonal Affective Disorder – may also help ease other types of depression.A ...

MAGIC’ mushrooms are better at treating depression than conventional medicine, according to a European study.  Depression is ...

Repetitive transcranial magnetic stimulation (rTMS). The FDA has approved this treatment to treat major depressive disorder. With rTMS, magnetic pulses are sent repeatedly to the nerve cells in ...

Bright-light therapy offers major advantages as an addition to treatment with antidepressants for non-seasonal depressive ...

Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt ...